Fox 19: Feeling down while homebound? You are not alone
UC psychologist offers tips for beating the blues during COVID-19
Fox 19 journalist Courtney King discussed mental health and the coronavirus’ impact with Maria Espinola, PsyD, assistant professor at the University of Cincinnati College of Medicine. Espinola, a license psychologist seeing patients at UC Health, explained that isolation is a risk-factor for mental health issues and physical.
“We are just social animals, we need that connection,” Espinola told Fox 19.
Espinola says she’s seen an increase in cases of depression since the Stay-at-Home orders went into effect, while many of those who already had the diagnosis have seen their symptoms worsen. “And then people who never had these challenges are now finding themselves experiencing high levels of stress and oftentimes depression,” she said.
Espinola offered some recommendations such as sticking to a regular routine every day. That structure can help manage some of the symptoms of isolation. “That means waking up at the same time, going to bed at the same time,” she said. “Engaging in healthy lifestyle choices, what you’re eating, making sure you are exercising.”
Related Stories
Taking a second look at surgery eligibility for patients with lung cancer who smoke
June 11, 2026
Researchers at the University of Cincinnati College of Medicine have found that patients who continue to smoke ahead of lung cancer surgery have a higher risk of pulmonary complications, but their short-term mortality rate is similar to patients who were able to stop smoking before surgery.. Their findings were published recently in the Journal of. American College of Surgeons
Patients with developmental disabilities may benefit with an integrated care model
June 9, 2026
Researchers from the University of Cincinnati and Ohio State University have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not. Their work was published in Disability and Health Journal.
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.